Search

Your search keyword '"Battegay, M"' showing total 1,707 results

Search Constraints

Start Over You searched for: Author "Battegay, M" Remove constraint Author: "Battegay, M"
1,707 results on '"Battegay, M"'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

3. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

4. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. Impact of hormonal therapy on HIV‐1 immune markers in cis women and gender minorities.

6. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

7. Time Trends in Causes of Death in People With Human Immunodeficiency Virus: Insights From the Swiss HIV Cohort Study

8. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

9. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

10. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

11. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

12. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

15. Healthcare delivery for HIV-positive people with tuberculosis in Europe

16. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

17. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

18. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

19. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

20. Promoting high standards of care for women living with HIV: position statement from the Women Against Viruses in Europe Working Group

21. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

23. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

24. VIBRA trial - Village-based refill of ART following home-based same-day ART initiation: a cluster-randomized clinical trial

25. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

27. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

28. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

29. Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area.

30. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

31. Health care provider communication training in rural Tanzania empowers HIV‐infected patients on antiretroviral therapy to discuss adherence problems

32. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

33. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

34. Hepatitis delta infection among persons living with HIV in Europe.

37. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

38. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

39. A highly virulent variant of HIV-1 circulating in the Netherlands

40. Children living with HIV in Europe: do migrants have worse treatment outcomes?

41. Similar but different: integrated phylogenetic analysis of Austrian and Swiss HIV-1 sequences reveal differences in transmission patterns of the local HIV-1 epidemics

42. Observational cohort study of rilpivirine (RPV) utilization in Europe

43. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

44. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

45. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

47. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

48. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

Catalog

Books, media, physical & digital resources